FONAR Corporation (NASDAQ:FONR) Has Attractive Fundamentals

Attractive stocks have exceptional fundamentals. In the case of FONAR Corporation (NASDAQ:FONR), there's is a financially-healthy company with a strong history of performance, trading at a great value. Below, I've touched on some key aspects you should know on a high level. For those interested in understanding where the figures come from and want to see the analysis, take a look at the report on FONAR here.

Advertisement

Flawless balance sheet and undervalued

In the previous year, FONR has ramped up its bottom line by 19%, with its latest earnings level surpassing its average level over the last five years. This illustrates a strong track record, leading to a satisfying return on equity of 23%. which is an notable feat for the company. FONR's ability to maintain an adequate level of cash to meet upcoming liabilities is a good sign for its financial health. This indicates that FONR has sufficient cash flows and proper cash management in place, which is a crucial insight into the health of the company. FONR's has produced operating cash levels of 59.85x total debt over the past year, which implies that FONR's management has put its borrowings into good use by generating enough cash to cover a sufficient portion of borrowings.

NasdaqCM:FONR Income Statement, August 15th 2019
NasdaqCM:FONR Income Statement, August 15th 2019

FONR is currently trading below its true value, which means the market is undervaluing the company's expected cash flow going forward. This mispricing gives investors the opportunity to buy into the stock at a cheap price compared to the value they will be receiving, should analysts' consensus forecast growth be correct. Also, relative to the rest of its peers with similar levels of earnings, FONR's share price is trading below the group's average. This bolsters the proposition that FONR's price is currently discounted.

NasdaqCM:FONR Intrinsic value, August 15th 2019
NasdaqCM:FONR Intrinsic value, August 15th 2019

Next Steps:

For FONAR, I've compiled three key aspects you should look at:

  1. Future Outlook: What are well-informed industry analysts predicting for FONR’s future growth? Take a look at our free research report of analyst consensus for FONR’s outlook.
  2. Dividend Income vs Capital Gains: Does FONR return gains to shareholders through reinvesting in itself and growing earnings, or redistribute a decent portion of earnings as dividends? Our historical dividend yield visualization quickly tells you what your can expect from FONR as an investment.
  3. Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of FONR? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.

About NasdaqCM:FONR

FONAR

Engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States.

Flawless balance sheet and overvalued.

Advertisement

Weekly Picks

JO
Jolt_Communications
ZENA logo
Jolt_Communications on ZenaTech ·

ZenaTech: A big bet on the rise of AI drones and drones-as-a-service

Fair Value:US$6.8569.9% undervalued
32 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
TR
tripledub
INTU logo
tripledub on Intuit ·

A Wonderful Business at a Not-So-Wonderful Price

Fair Value:US$50016.7% undervalued
20 users have followed this narrative
0 users have commented on this narrative
18 users have liked this narrative
FA
A1AKK logo
FA_Trader on A1 A.K. Koh Group Berhad ·

A1 A.K. Koh Group Berhad: A simple local food story that could ride on Visit Malaysia 2026

Fair Value:RM 0.3345.5% undervalued
7 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
KA
AII logo
kaladorm on American Integrity Insurance Group ·

Priced for worse weather, but undervalued even for a high hurricane season

Fair Value:US$37.1949.9% undervalued
11 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative

Updated Narratives

YI
HSAI logo
yiannisz on Hesai Group ·

The First Real Lidar Winner

Fair Value:US$27.0731.9% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VE
Vestra
UTHR logo
Vestra on United Therapeutics ·

United Therapeutics Corp. (UTHR): The "TETON-1" Breakthrough and the $618.00 Pre-Market Moonshot

Fair Value:US$67522.5% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VE
Vestra
NKE logo
Vestra on NIKE ·

Nike Inc. (NKE): The "Innovation Reset" and the Battle for Brand Supremacy

Fair Value:US$7228.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

YA
SOFI logo
Yang_ on SoFi Technologies ·

SoFi Technologies: The Apex Aggregator and the Infrastructure of the Modern Financial System

Fair Value:US$22.9833.7% undervalued
49 users have followed this narrative
0 users have commented on this narrative
36 users have liked this narrative
PD
VRT logo
pdixit1 on Vertiv Holdings Co ·

The Infrastructure AI Cannot Be Built Without

Fair Value:US$408.6438.6% undervalued
40 users have followed this narrative
3 users have commented on this narrative
18 users have liked this narrative
ZA
PME logo
ZayaanS on Pro Medicus ·

Pro Medicus: The Market Is Confusing a Lumpy Quarter With a Broken Business

Fair Value:AU$196.7841.8% undervalued
33 users have followed this narrative
7 users have commented on this narrative
21 users have liked this narrative